Breaking: Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.

The company singled out the list price of its popular weight-loss drug Mounjaro in the U.K.

Log In    Subscribe BREAKING NEWS   Eli Lilly says it will raise drug prices in Europe to 'make them lower' in U.S. By Elaine Chen and Daniel Payne Adobe The announcement is among the first moves by a major drugmaker to raise prices abroad in order to lower them in the U.S., in line with President Trump's agenda. But the impact on patients in U.S. and overseas remains unclear. READ MORE Sign up for Biotech Scorecard Unfiltered, uncompromising analysis on the biotech world. Learn more. In Case You Missed It 1   Inside the American Medical Association's sudden strategy shift in Washington By Theresa Gaffney 2   Trump administration leaves biotech investors more wary than ever of funding mRNA vaccines By Jonathan Wosen and Allison DeAngelis 3   Exclusive: Drugmakers form new group to lobby on impact of Medicare drug price negotiations By John Wilkerson 4   Duke scientists seemed to have developed a 'Holy Grail' of cancer treatment. Then the truth came out By Mike Damiano — Boston Globe Don't miss out on another STAT Investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us